These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12788588)

  • 1. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome.
    Harborne L; Fleming R; Lyall H; Norman J; Sattar N
    Lancet; 2003 May; 361(9372):1894-901. PubMed ID: 12788588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of metformin in polycystic ovary syndrome: a meta-analysis.
    Creanga AA; Bradley HM; McCormick C; Witkop CT
    Obstet Gynecol; 2008 Apr; 111(4):959-68. PubMed ID: 18378757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
    Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
    Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of metformin in polycystic ovary syndrome.
    Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
    Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
    Katsiki N; Hatzitolios AI
    Curr Opin Obstet Gynecol; 2010 Dec; 22(6):466-76. PubMed ID: 20724929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and metformin in polycystic ovary syndrome.
    Ben-Haroush A; Yogev Y; Fisch B
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
    Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
    Palomba S; Falbo A; Zullo F; Orio F
    Endocr Rev; 2009 Feb; 30(1):1-50. PubMed ID: 19056992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients.
    Palomba S; Falbo A; Orio F; Zullo F
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):364-73. PubMed ID: 18660688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and glitazones: do they really help PCOS patients?
    Pillai A; Bang H; Green C
    J Fam Pract; 2007 Jun; 56(6):444-53. PubMed ID: 17543254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is metformin therapy for polycystic ovary syndrome safe during pregnancy?
    Brock B; Smidt K; Ovesen P; Schmitz O; Rungby J
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):410-2. PubMed ID: 15910403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.
    Lord J; Thomas R; Fox B; Acharya U; Wilkin T
    BJOG; 2006 Jul; 113(7):817-24. PubMed ID: 16827766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
    Teede HJ; Meyer C; Norman RJ
    Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
    Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F
    Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial.
    Moro F; Morciano A; Tropea A; Sagnella F; Palla C; Scarinci E; Ciardulli A; Martinez D; Familiari A; Liuzzo G; Tritarelli A; Cosentino N; Niccoli G; Crea F; Lanzone A; Apa R
    Reprod Sci; 2013 Dec; 20(12):1508-17. PubMed ID: 23690338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metformin for the treatment of polycystic ovary syndrome].
    Gundelach T; Rodewald M; Bekes I; Janni W; Hancke K
    Med Monatsschr Pharm; 2016 Feb; 39(2):75-8. PubMed ID: 26983336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Christakou CD; Kandaraki E; Economou FN
    Eur J Endocrinol; 2010 Feb; 162(2):193-212. PubMed ID: 19841045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.